Universal Health Services (NYSE:UHS) Price Target Raised to $183.00

Universal Health Services (NYSE:UHS) had its price target raised by investment analysts at TD Cowen from $181.00 to $183.00 in a report released on Tuesday, Benzinga reports. The brokerage presently has a “hold” rating on the health services provider’s stock. TD Cowen’s target price indicates a potential upside of 7.67% from the stock’s previous close.

Several other research analysts have also recently issued reports on the company. JPMorgan Chase & Co. upped their price objective on Universal Health Services from $144.00 to $182.00 and gave the stock a “neutral” rating in a research report on Wednesday, March 13th. Stephens reaffirmed an “equal weight” rating and set a $185.00 price objective on shares of Universal Health Services in a research report on Thursday, April 25th. The Goldman Sachs Group upped their price objective on Universal Health Services from $170.00 to $189.00 and gave the stock a “buy” rating in a research report on Monday, March 4th. UBS Group upped their price objective on Universal Health Services from $152.00 to $177.00 and gave the stock a “neutral” rating in a research report on Thursday, February 29th. Finally, Barclays upped their price objective on Universal Health Services from $181.00 to $189.00 and gave the stock an “equal weight” rating in a research report on Friday. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $182.79.

Universal Health Services Stock Up 0.5 %

UHS traded up $0.85 on Tuesday, hitting $169.97. 122,897 shares of the company were exchanged, compared to its average volume of 582,101. Universal Health Services has a twelve month low of $119.90 and a twelve month high of $183.61. The company has a market cap of $11.43 billion, a price-to-earnings ratio of 14.43, a price-to-earnings-growth ratio of 0.82 and a beta of 1.24. The company has a current ratio of 1.38, a quick ratio of 1.28 and a debt-to-equity ratio of 0.75. The firm has a 50-day moving average price of $170.76 and a two-hundred day moving average price of $154.00.

Universal Health Services (NYSE:UHS) last released its earnings results on Wednesday, April 24th. The health services provider reported $3.70 EPS for the quarter, topping the consensus estimate of $3.14 by $0.56. Universal Health Services had a return on equity of 13.34% and a net margin of 5.57%. The firm had revenue of $3.84 billion during the quarter, compared to analysts’ expectations of $3.78 billion. During the same period in the previous year, the firm posted $2.34 EPS. Universal Health Services’s revenue for the quarter was up 10.8% on a year-over-year basis. On average, equities analysts predict that Universal Health Services will post 13.47 earnings per share for the current year.

Insider Buying and Selling at Universal Health Services

In other Universal Health Services news, CFO Steve Filton sold 35,000 shares of the company’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $176.82, for a total transaction of $6,188,700.00. Following the completion of the sale, the chief financial officer now directly owns 68,785 shares of the company’s stock, valued at approximately $12,162,563.70. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 16.10% of the stock is owned by company insiders.

Institutional Trading of Universal Health Services

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. JPMorgan Chase & Co. raised its stake in Universal Health Services by 3.5% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,090,010 shares of the health services provider’s stock valued at $137,047,000 after acquiring an additional 37,243 shares during the last quarter. UBS Group AG raised its stake in shares of Universal Health Services by 51.2% during the 3rd quarter. UBS Group AG now owns 62,949 shares of the health services provider’s stock worth $7,915,000 after buying an additional 21,325 shares in the last quarter. Lazard Asset Management LLC raised its stake in shares of Universal Health Services by 4,622.3% during the 3rd quarter. Lazard Asset Management LLC now owns 16,906 shares of the health services provider’s stock worth $2,125,000 after buying an additional 16,548 shares in the last quarter. Assenagon Asset Management S.A. raised its stake in shares of Universal Health Services by 16.7% during the 4th quarter. Assenagon Asset Management S.A. now owns 53,239 shares of the health services provider’s stock worth $8,116,000 after buying an additional 7,616 shares in the last quarter. Finally, Aigen Investment Management LP purchased a new position in shares of Universal Health Services during the 3rd quarter worth approximately $466,000. 86.05% of the stock is owned by hedge funds and other institutional investors.

Universal Health Services Company Profile

Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.